Charting the Future: What Lies Ahead For Medical Device Manufacturers In 2026

By Paul Spencer, President of Biomedical at dsm-firmenich

Medical device manufacturers are stepping into 2026 with a mix of big opportunities and growing pressures. Patient expectations are changing fast, regulations are tightening, and device designs are becoming more advanced — all of which push teams to rethink how they innovate. Biomaterials play a huge role in this shift, and companies are looking for partners who can collaborate early, move quickly, and help them navigate increasing complexity.

Global trade challenges, shifting supply chains, and rising demands for sourcing resilience are also reshaping what manufacturers need from their material partners. It’s no longer just about performance; it’s about long-term stability, geographic flexibility, and reducing risk across the entire product lifecycle. At the same time, emerging healthcare trends — like the rapid growth of metabolic health solutions and continuous glucose monitoring — are driving the need for devices that work better, last longer, and support everyday use. Advanced biomaterials and coatings are becoming essential tools for improving device–tissue interaction and boosting long-term outcomes.